MedPath

Valproic

These highlights do not include all the information needed to use VALPROIC ACID CAPSULES safely and effectively. See full prescribing information for VALPROIC ACID CAPSULES . VALPROIC ACID Capsule s , for oral use. Initial U.S. Approval: 1978

Approved
Approval ID

cef3e335-5891-412f-89c4-79fcd2f145b7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2021

Manufacturers
FDA

Actavis Pharma, Inc.

DUNS: 119723554

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valproic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0591-4012
Application NumberANDA073229
Product Classification
M
Marketing Category
C73584
G
Generic Name
Valproic Acid
Product Specifications
Route of AdministrationORAL
Effective DateMay 1, 2021
FDA Product Classification

INGREDIENTS (5)

VALPROIC ACIDActive
Quantity: 250 mg in 1 1
Code: 614OI1Z5WI
Classification: ACTIB
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
PEANUT OILInactive
Code: 5TL50QU0W4
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Valproic - FDA Drug Approval Details